RecruitingNot ApplicableNCT04025164

Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery

Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast Conserving Surgery:a Multi-center Phase III Randomized Clinical Trial


Sponsor

Fudan University

Enrollment

4,052 participants

Start Date

Jul 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The study was designed to investigate whether hypofractionated radiotherapy(HF-RT) is noninferior to conventionally fractionated radiotherapy (CF-RT) in terms of tumor loco-regional control for patients after breast conserving surgery


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Inclusion Criteria15

  • Female
  • Age18-70 years
  • Imaging examination confirmed single lesion. if the tumor is multiple, it needs to be removed by single quadrantectomy
  • Receive breast conserving surgery with negative margins
  • Axillary lymph nodes treatment: Sentinel lymph node biopsy or level I/II axillary lymph node dissection. If the sentinel lymph node is negative, the axillary lymph node dissection can be omitted. If it is positive, level I/II axillary lymph node dissection with or more than 10 lymph nodes is needed.
  • The tumor bed is labeled with clips and it can be drawn on the treatment planning system.
  • Pathologically confirmed invasive breast cancer
  • Pathologically stage is T1-3N0-3M0
  • Immunohistochemical examination is conducted to determine the status of ER, PR, HER2, Ki67 after surgery
  • No distant metastases
  • No supraclavicular or internal mammary nodes metastases
  • No neoadjuvant chemotherapy
  • Fit for postoperative radiotherapy. No contraindications to radiotherapy
  • KPS≥80
  • Signed informed consent

Exclusion Criteria15

  • T4 or M1 breast cancer
  • Supraclavicular or internal mammary nodes metastases
  • Pathologically confirmed DCIS only without an invasive component
  • Bilateral breast cancer or historically confirmed contralateral invasive breast cancer
  • Treated with neoadjuvant chemotherapy or neoadjuvant endocrine therapy
  • Multiple lesions can not be removed by single quadrantectomy
  • Suspicious unresected and microcalcification, densities, or palpable abnormalities (in the ipsilateral or contralateral breast)
  • KPS ≤ 70
  • Patients with severe non-malignant comorbidity in cardiovascular or respiration system
  • Concurrent or previous malignancy excluding basal or squamous cell carcinoma of the skin
  • Previous radiotherapy to the chest wall or regional lymph node areas
  • Patients with medical contraindication for radiotherapy: systemic lupus erythematosus, cirrhosis
  • Pregnant or lactating
  • Conditions indicating that the patient cannot go through the radiation therapy or follow up
  • Unable or unwilling to sign informed consent

Interventions

RADIATIONHypofractionated Radiotherapy

daily fractions, 2.66 Gy/3.2 Gy per fraction to whole breast/tumor bed, five fractions per week

RADIATIONConventional fractionated Radiotherapy

daily fractions, 2 Gy per fraction, five fractions per week


Locations(5)

Guizhou Provincial People's Hospital

Guiyang, Guizhou, China

Suzhou Municipal hospital

Suzhou, Jiangsu, China

The Second Hospital of Dalian Medical University

Dalian, Liaoning, China

Shanghai Huangpu District Central Hospital

Shanghai, Shanghai Municipality, China

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04025164


Related Trials